Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034

被引：0
|
作者：
Van den Bent, Martin [1 ]
Brandes, Alba
Rampling, Roy [2 ]
Kouwenhoven, Mathilde [3 ]
Kros, Johan M. [4 ]
Carpentier, Antoine [5 ]
Clement, Paul [6 ]
Klughammer, Barbara [7 ]
Bakker, Brenda [8 ]
Lacombe, Denis [9 ]
Gorlia, Thierry [9 ]
机构：
[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[2] Beatson Oncol Ctr, Glasgow, Lanark, Scotland
[3] EEA, Rotterdam, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] CHU Pitie Salpetriere, Paris, France
[6] Acad Ziekenhuis, Louvain, Belgium
[7] Hoffmann La Roche AG, Basel, Switzerland
[8] Erasme Univ Hosp, B-1070 Brussels, Belgium
[9] Eortc Data Ctr, Brussels, Belgium
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [21] Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group
    Stupp, R
    Mason, WP
    Van Den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, M
    Brandes, AA
    Cairncross, G
    Lacombe, D
    Mirimanoff, RO
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 1S - 1S
  • [22] Low Dose Fractionated Radiation Therapy as a ChemoPotentiator of Salvage Temozolomide (TMZ) for Recurrent Anaplastic Astrocytoma (AA) and Glioblastoma Multiforme (GBM): A Single-Arm Phase I/II Trial
    Lin, T. A.
    Ke, S.
    Hu, C.
    Assadi, R. K.
    Huang, J.
    Kleinberg, L. R.
    Mukherjee, D.
    Weingart, J.
    Holdhoff, M.
    Grossman, S.
    Redmond, K. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S85 - S85
  • [23] LONG-TERM SURVIVAL OF A PEDIATRIC PATIENT WITH GLIOBLASTOMA MULTIFORME (GBM) FOLLOWING MULTIPLE TREATMENTS WITH CARMUSTINE (BCNU) WAFERS AND TEMOZOLOMIDE (TMZ)
    Ollero, A.
    Marquez-Rivas, J.
    Ramirez, G.
    Quiroga, E.
    Gimenez-Pando, J.
    Segovia-Vergel, C.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1084 - 1085
  • [24] A phase I/II study of temozolomide (TMZ) and the farnesyltransferase inhibitor (FTI), tipifarnib (Zarnestra, ZAR) in recurrent glioblastoma (GBM)
    Gilbert, Mark
    Gaupp, Patricia
    Ictech, Sandra
    Hess, Ken
    Groves, Morris
    Levin, Victor
    Conrad, Charles
    Puduvalli, Vinay
    Colman, Howard
    De Groot, John
    Hsu, Sigmond
    De Porre, Peter
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2007, 9 (04) : 524 - 524
  • [25] A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Clarke, Jennifer
    Sul, Joohee
    DeAngelis, Lisa
    Lassman, Andrew
    Hormigo, Adilia
    Nolan, Craig
    Gavrilovic, Igor
    Gu, Bin
    Panageas, Kathy
    Abrey, Lauren
    NEURO-ONCOLOGY, 2007, 9 (04) : 530 - 530
  • [26] Phase II trial of radiation therapy/temozolomide followed by temozolomide/sorafenib in the first-line treatment of glioblastoma multiforme (GBM)
    Lamar, R. E.
    Spigel, D. R.
    Burris, H. A.
    Markus, T. M.
    Kuzur, M.
    Ervin, T.
    Fichtel, L.
    Greco, F. A.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients
    Vinjamuri, Mridula
    Adumala, Rakesh R.
    Altaha, Ramin
    Hobbs, Gerald R.
    Crowell, Edward B., Jr.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (02) : 221 - 225
  • [28] Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients
    Mridula Vinjamuri
    Rakesh R. Adumala
    Ramin Altaha
    Gerald R. Hobbs
    Edward B. Crowell
    Journal of Neuro-Oncology, 2009, 91 : 221 - 225
  • [29] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Grossman, S. A.
    Ye, X.
    Chamberlain, M. C.
    Mikkelsen, T.
    Batchelor, T. T.
    Desideri, S.
    Piantadosi, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase II study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme
    Sathornsumetee, S.
    Vredenburgh, J. J.
    Rich, J. N.
    Desjardins, A.
    Quinn, J. A.
    Mathe, A. E.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345